Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

by | Sep 5, 2025 | Clinical Trials | 0 comments

​ Conditions: Prostate Cancer Castration-resistant Prostate Cancer; Breast Cancer; Colo-rectal Cancer; Lung Cancer (Non-Small Cell); Pancreas Cancer, Duct Cell Adenocarcinoma

Interventions: Drug: ADC

Sponsors: MBrace Therapeutics

Not yet recruiting Conditions: Prostate Cancer Castration-resistant Prostate Cancer; Breast Cancer; Colo-rectal Cancer; Lung Cancer (Non-Small Cell); Pancreas Cancer, Duct Cell Adenocarcinoma
Interventions: Drug: ADC
Sponsors: MBrace Therapeutics
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *